Ipsen Stock

Ipsen Dividend

The Dividend of Ipsen (IPN.PA) as of Aug 22, 2026 is 1.40 EUR. In the previous year, Dividend was 1.20 EUR — a change of 16.67% (higher).

Dividend

1.40EUR

YoY

16.67%

Dividend yield

0.85 %

Last updated:

How much dividend does Ipsen 2026 pay?

According to the latest status from August 2026, Ipsen paid a total of 1.40 EUR per share in dividends within the last 12 months. With the current Ipsen price of 164.30 EUR, this corresponds to a dividend yield of 0.87 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 0.85%. The payout ratio is around 26% of earnings. The dividend has grown at 4.6% per year over the past 19 years.

Historical Ipsen Dividends

A dividend is paid times per year. Last year, the payout months were and July.

PaydateDividend
7/4/20251.40EUR
6/30/20241.20EUR
7/2/20231.20EUR
7/1/20221.20EUR
7/1/20211.00EUR
7/3/20201.00EUR
7/1/20191.00EUR
7/4/20181.00EUR
7/9/20170.85EUR
7/2/20160.85EUR
6/29/20150.85EUR
7/9/20140.80EUR
7/5/20130.80EUR
7/6/20120.80EUR
7/1/20110.80EUR
7/1/20100.75EUR
7/9/20090.70EUR
7/6/20080.66EUR
7/6/20070.60EUR
7/2/20060.60EUR

Ipsen dividend history and estimates

In 2025, Ipsen paid a dividend amounting to 1.40 EUR. Dividend means that Ipsen distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.00 EUR
0.00 EUR
Jan 1, 2022
1.20 EUR
0.00 EUR
Jan 1, 2023
1.20 EUR
0.00 EUR
Jan 1, 2024
1.20 EUR
0.00 EUR
Jan 1, 2025
1.40 EUR
0.00 EUR
Jan 1, 2026 (e)
0.00 EUR
1.50 EUR
Jan 1, 2027 (e)
0.00 EUR
1.60 EUR
Jan 1, 2028 (e)
0.00 EUR
1.71 EUR

Is the Ipsen Dividend Safe?

Ipsen has been increasing the dividend for 1 years.

Over the past 10 years, Ipsen has increased it by an annual 5.12%.

Over a five-year period, the distribution rose by 6.96%.

Analysts expect a Dividend Increase of 3.42% for the current fiscal year.

Ipsen dividend payout ratio

In 2025, Ipsen had a payout ratio of 25.89%. The payout ratio indicates the percentage of the company's profits that Ipsen distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
12.83 %
Jan 1, 2022
15.36 %
Jan 1, 2023
15.55 %
Jan 1, 2024
28.89 %
Jan 1, 2025
25.89 %
Jan 1, 2026 (e)
9.80 %
Jan 1, 2027 (e)
11.58 %
Jan 1, 2028 (e)
13.02 %

Dividend Details

Understanding Ipsen's Dividend Distributions

Ipsen’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Ipsen's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Ipsen's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Ipsen’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Ipsen Stock analysis

What does Ipsen do? Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ipsen stock

Over the past 12 months, Ipsen paid a dividend of 1.40 EUR . This corresponds to a dividend yield of about 0.85 %. For the coming 12 months, Ipsen is expected to pay a dividend of 1.60 EUR.

The current dividend yield of Ipsen is 0.85 %.

Ipsen pays a dividend, distributed in the months of , , , .

Ipsen paid dividends every year for the past 20 years.

For the upcoming 12 months, dividends amounting to 1.60 EUR are expected. This corresponds to a dividend yield of 0.99 %.

Ipsen is assigned to the 'Health' sector.

To receive the latest dividend of Ipsen from amounting to 1.4 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Ipsen distributed 1.2 EUR as dividends.

The dividends of Ipsen are distributed in EUR.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Ipsen